Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Famotidine
14 general benefit · 2 not a benefit
AG-Famotidine · DIN 02509970 · 20 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
AG-Famotidine · DIN 02509970
Manufacturer: Angita Pharma Inc.; listing date 2021-12-17
Health Canada: Marketed since 2021-09-21 · brand AG-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Angita pharma inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAG-Famotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02509970)
Source record
DIN 02509970: AG-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id ANG
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02509970
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99923
Interchangeable products
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02509970
Shortage record checked October 6, 2026
Famotidine · DIN 02351102 · 20 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Famotidine · DIN 02351102
Manufacturer: Sanis Health Inc.; listing date 2011-12-15
Health Canada: Marketed since 2024-10-24 · brand FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFamotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02351102)
Source record
DIN 02351102: Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id SAI
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02351102
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83631
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: anticipated shortage (last updated May 25, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02351102
Shortage record checked October 6, 2026
Famotidine · DIN 02549107 · 20 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Famotidine · DIN 02549107
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2025-01-31
Health Canada: Marketed since 2024-11-13 · brand FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFamotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02549107)
Source record
DIN 02549107: Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id SIV
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02549107
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103798
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02549107
Shortage record checked October 6, 2026
Jamp Famotidine · DIN 02507749 · 20 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Famotidine · DIN 02507749
Manufacturer: Jamp Pharma Corporation; listing date 2021-10-29
Health Canada: Marketed since 2021-09-21 · brand JAMP FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Famotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02507749)
Source record
DIN 02507749: Jamp Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id JPC
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02507749
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99714
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02507749
Shortage record checked October 6, 2026
Mint-Famotidine · DIN 02538628 · 20 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Mint-Famotidine · DIN 02538628
Manufacturer: Mint Pharmaceuticals Inc.; listing date 2024-07-31
Health Canada: Marketed since 2024-04-30 · brand MINT-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Mint pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMint-Famotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02538628)
Source record
DIN 02538628: Mint-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id MIN
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02538628
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102732
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02538628
Shortage record checked October 6, 2026
Teva-Famotidine · DIN 02022133 · 20 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Famotidine · DIN 02022133
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2014-04-03 · brand TEVA-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Famotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02022133)
Source record
DIN 02022133: Teva-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id TEV
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02022133
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13654
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Shortage status: resolved shortage (ended February 11, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02022133
Shortage record checked October 6, 2026
AG-Famotidine · DIN 02509989 · 40 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
AG-Famotidine · DIN 02509989
Manufacturer: Angita Pharma Inc.; listing date 2021-12-17
Health Canada: Marketed since 2021-09-21 · brand AG-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Angita pharma inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAG-Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02509989)
Source record
DIN 02509989: AG-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id ANG
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02509989
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99924
Interchangeable products
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02509989
Shortage record checked October 6, 2026
Famotidine · DIN 02351110 · 40 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Famotidine · DIN 02351110
Manufacturer: Sanis Health Inc.; listing date 2011-12-15
Health Canada: Marketed since 2024-10-24 · brand FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFamotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02351110)
Source record
DIN 02351110: Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id SAI
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02351110
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83632
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: resolved shortage (ended March 1, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02351110
Shortage record checked October 6, 2026
Famotidine · DIN 02549115 · 40 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Famotidine · DIN 02549115
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2025-01-31
Health Canada: Marketed since 2024-11-13 · brand FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFamotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02549115)
Source record
DIN 02549115: Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id SIV
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02549115
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103799
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02549115
Shortage record checked October 6, 2026
Jamp Famotidine · DIN 02507757 · 40 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Jamp Famotidine · DIN 02507757
Manufacturer: Jamp Pharma Corporation; listing date 2021-10-29
Health Canada: Marketed since 2021-09-17 · brand JAMP FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02507757)
Source record
DIN 02507757: Jamp Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id JPC
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02507757
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99715
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02507757
Shortage record checked October 6, 2026
Mint-Famotidine · DIN 02538636 · 40 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Mint-Famotidine · DIN 02538636
Manufacturer: Mint Pharmaceuticals Inc.; listing date 2024-07-31
Health Canada: Marketed since 2024-04-30 · brand MINT-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Mint pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMint-Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02538636)
Source record
DIN 02538636: Mint-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id MIN
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02538636
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102733
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02538636
Shortage record checked October 6, 2026
Teva-Famotidine · DIN 02022141 · 40 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Famotidine · DIN 02022141
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2014-04-03 · brand TEVA-FAMOTIDINE · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02022141)
Source record
DIN 02022141: Teva-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id TEV
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02022141
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13655
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Shortage status: resolved shortage (ended February 11, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02022141
Shortage record checked October 6, 2026
Apo-Famotidine · DIN 01953842 · 20 mg · tablet
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Famotidine · DIN 01953842
Manufacturer: Apotex Inc.; listing date 1996-10-01
Health Canada: Dormant since 2017-08-04 · brand APO-FAMOTIDINE TAB 20MG USP · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Cardinal health 200 inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Famotidine: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2658). What the ministry pays, not the patient.
Ministry pays: $0.2658 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01953842)
Source record
DIN 01953842: Apo-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id APX
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2658; ministry $0.2658
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01953842
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13572
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Pepcid · DIN 00710121 · not recorded
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: discontinued (September 14, 2018, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01953842
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 4, 2017 — choose a marketed DIN from the same-category list.
Apo-Famotidine · DIN 01953834 · 40 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.Discontinued July 21, 2024 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Apo-Famotidine · DIN 01953834
Manufacturer: Apotex Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2024-07-21 · brand APO-FAMOTIDINE TAB 40MG USP · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordApo-Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Ministry pays: $0.4834 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01953834)
Source record
DIN 01953834: Apo-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id APX
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01953834
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13583
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: discontinued (September 14, 2018, reported by APOTEX INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01953834
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 21, 2024 — choose a marketed DIN from the same-category list.
Pepcid · DIN 00710121 · 20 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.Discontinued July 15, 2013 · checked November 17, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pepcid · DIN 00710121
Manufacturer: Merck Frosst Canada Ltd.; listing date 1996-10-01
Health Canada: Cancelled post market since 2013-07-15 · brand PEPCID TAB 20MG · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 20 MG · company Agropharm technologies, a division of 1145565 ont. ltd. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPepcid: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00710121)
Source record
DIN 00710121: Pepcid
Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y
Item: 564000025; group id 678; item number 1693; lccId None; manufacturer id MFC
Source form: Tab; strength: 20mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00710121
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=7087
Interchangeable products
AG-Famotidine · DIN 02509970 · $0.2658
Apo-Famotidine · DIN 01953842 · $0.2658
Famotidine · DIN 02351102 · $0.2658
Famotidine · DIN 02549107 · $0.2658
Jamp Famotidine · DIN 02507749 · $0.2658
Mint-Famotidine · DIN 02538628 · $0.2658
Teva-Famotidine · DIN 02022133 · $0.2658
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00710121
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 15, 2013 — choose a marketed DIN from the same-category list.
Pepcid · DIN 00710113 · 40 mg · tablet
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.Discontinued July 15, 2013 · checked November 17, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2013-07-15 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pepcid · DIN 00710113
Manufacturer: Merck Frosst Canada Ltd.; listing date 1996-10-01
Health Canada: Cancelled post market since 2013-07-15 · brand PEPCID TAB 40MG · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Merck canada inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPepcid: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00710113)
Source record
DIN 00710113: Pepcid
Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id MFC
Source form: Tab; strength: 40mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00710113
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=7088
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Apo-Famotidine · DIN 01953834 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00710113
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 15, 2013 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (A02B, A02BA): coverage varies; not interchangeable
- Cimetidine: general benefit, not a benefit
- Nizatidine (Axid): general benefit
- Ranitidine (Zantac): general benefit, not a benefit
- Misoprostol (Cytotec): general benefit, not a benefit
- Pantoprazole (Tecta): general benefit
- Rabeprazole (Pariet): general benefit
7 more in the class list below
Other drugs in the same formulary class (56:40 Miscellaneous G.I. Drugs) and how they are covered
Matched class: 56:40 Miscellaneous G.I. Drugs
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: BUDESONIDE, MESALAZINE, NIZATIDINE, OLSALAZINE SODIUM, PANTOPRAZOLE MAGNESIUM, RABEPRAZOLE SODIUM, SUCRALFATE
Some products covered without a code (check the product listing): 5-AMINOSALICYLIC ACID, CIMETIDINE, DOMPERIDONE MALEATE, LACTULOSE, METOCLOPRAMIDE HCL, MISOPROSTOL, RANITIDINE HCL
56:40 Miscellaneous G.I. Drugs
· 10 products · General benefit (5), Listed, not a benefit (5) · strengths: 200mg, 300mg, 400mg, 600mg, 800mg · Tab
· 2 products · General benefit · strengths: 150mg, 300mg · Cap
· 23 products · Listed, not a benefit (3), General benefit (20) · strengths: 15mg/mL, 150mg, 300mg · Oral Sol, Tab
· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 100mcg, 200mcg · Tab
· 6 products · General benefit · strengths: 40mg · Ent Coated Tab
· 16 products · General benefit · strengths: 10mg, 20mg · Tab
· 4 products · General benefit · strengths: 1g/5mL, 1g · Oral Susp, Tab
· 16 products ·
Limited Use, codes 293, 295, 297, 401, 402 · strengths: 15mg, 30mg · DR Cap
· 2 products · Listed, not a benefit (1),
Limited Use, codes 306, 307 (1) · strengths: 30mg & 500mg & 500mg · Tab/Cap Pk
· 19 products · Off-Formulary Interchangeable, not an ODB benefit (4), Listed, not a benefit (2),
Limited Use, codes 293, 297, 401, 402 (13) · strengths: 10mg, 20mg · DR Cap
· 30 products · Off-Formulary Interchangeable, not an ODB benefit (10),
Limited Use, codes 293, 295, 297, 401, 402 (20) · strengths: 20mg, 40mg · Ent Tab
· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 30mg, 60mg · DR Cap
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 56:40
and 10 more
Full class listing
Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:12 Cathartics, 56:16 Digestants, 56:22 Antiemetics and Antinauseants
Same formulary class, not same indication: class membership alone does not establish equivalent uses.